scholarly journals Neurotoxicity including posterior reversible encephalopathy syndrome after initiation of calcineurin inhibitors in transplanted methylmalonic acidemia patients: Two case reports and review of the literature

JIMD Reports ◽  
2020 ◽  
Vol 51 (1) ◽  
pp. 89-104 ◽  
Author(s):  
Femke Molema ◽  
Monique Williams ◽  
Janneke Langendonk ◽  
Sarwa Darwish‐Murad ◽  
Jacqueline Wetering ◽  
...  
2020 ◽  
Vol 13 (2) ◽  
pp. 1013-1019 ◽  
Author(s):  
Anannya Patwari ◽  
Vineel Bhatlapenumarthi ◽  
Sheila K. Pascual

We report here a rare case of atypical posterior reversible encephalopathy syndrome (PRES) due to oral tyrosine kinase inhibitor cabozantinib. No case reports of such have been found in our literature search. The patient, a 70-year-old female with metastatic renal cell cancer on oral tyrosine kinase inhibitor cabozantinib, was brought into the emergency room because of confusion and seizures, found to have elevated blood pressure and atypical MRI findings consistent with PRES due to cabozantinib.


2015 ◽  
Vol 32 (5) ◽  
pp. 857-863 ◽  
Author(s):  
Lain Hermes González Quarante ◽  
José Hinojosa Mena-Bernal ◽  
Beatriz Pascual Martín ◽  
Marta Ramírez Carrasco ◽  
María Jesús Muñoz Casado ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document